(Q46631570)

23 December 2017

title

beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells (English)

1 reference

23 December 2017

author name string

Naidu A

series ordinal

1

1 reference

23 December 2017

Quon D

series ordinal

2

1 reference

23 December 2017

Cordell B

series ordinal

3

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

23 December 2017

Journal of Biological Chemistry

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 December 2017

volume

270

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

1369-1374

1 reference

23 December 2017

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Expression of the Alzheimer amyloid precursor gene transcripts in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Synthesis and characterization of the Kunitz protease-inhibitor domain of the β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Protease-specificity of Kunitz inhibitor domain of Alzheimer's disease amyloid protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

beta-Amyloid formation as a potential therapeutic target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Normal and abnormal biology of the beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

beta-Amyloid neurotoxicity: a discussion of in vitro findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.3.1369

21 January 2018

Identifiers

DOI

10.1074/JBC.270.3.1369

1 reference

23 December 2017

1 reference

23 December 2017